Buy Innoviva Stock | INVA Stock Price & Latest News | Public
INVA

Innoviva

$0.00 (0.00%)Today

    About INVA

    Innoviva, Inc. is engaged in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.69
    0.46
    0.23
    0
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    $0.41

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,11B
    Volume21,98k
    Price-to-Earnings Ratio5.62
    Dividend Rate
    Dividend Yield
    1 Year High$15.62
    1 Year Low$7.58
    Open$10.96
    High$10.96
    Low$10.58

    Buy any stock with any amount of money.

    Download the App
    Download the app